Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression

Author:

Molina OscarORCID,Ortega-Sabater Carmen,Thampi NamithaORCID,Fernández-Fuentes NarcísORCID,Guerrero-Murillo MercedesORCID,Martínez-Moreno AlbaORCID,Vinyoles MeritxellORCID,Velasco-Hernández TalíaORCID,Bueno Clara,Trincado Juan LORCID,Granada Isabel,Campos Diana,Giménez Carles,Boer Judith MORCID,den Boer Monique L,Calvo Gabriel FORCID,Camós Mireia,Fuster Jose-LuisORCID,Velasco Pablo,Ballerini PaolaORCID,Locatelli FrancoORCID,Mullighan Charles GORCID,Spierings Diana C JORCID,Foijer FlorisORCID,Pérez-García Víctor MORCID,Menéndez PabloORCID

Abstract

AbstractChromosomal instability (CIN) lies at the core of cancer development leading to aneuploidy, chromosomal copy-number heterogeneity (chr-CNH) and ultimately, unfavorable clinical outcomes. Despite its ubiquity in cancer, the presence of CIN in childhood B-cell acute lymphoblastic leukemia (cB-ALL), the most frequent pediatric cancer showing high frequencies of aneuploidy, remains unknown. Here, we elucidate the presence of CIN in aneuploid cB-ALL subtypes using single-cell whole-genome sequencing of primary cB-ALL samples and by generating and functionally characterizing patient-derived xenograft models (cB-ALL-PDX). We report higher rates of CIN across aneuploid than in euploid cB-ALL that strongly correlate with intraclonal chr-CNH and overall survival in mice. This association was further supported by in silico mathematical modeling. Moreover, mass-spectrometry analyses of cB-ALL-PDX revealed a “CIN signature” enriched in mitotic-spindle regulatory pathways, which was confirmed by RNA-sequencing of a large cohort of cB-ALL samples. The link between the presence of CIN in aneuploid cB-ALL and disease progression opens new possibilities for patient stratification and offers a promising new avenue as a therapeutic target in cB-ALL treatment.

Funder

Ministerio de Economía y Competitividad

Fundación Josep Carreras Contra la Leucemia

MEC | Instituto de Salud Carlos III

Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca

Fundación Científica Asociación Española Contra el Cáncer

Ministerio de Ciencia e Innovación

Publisher

Springer Science and Business Media LLC

Subject

Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3